Percentage of Novartis AG's pharmaceuticals revenue by therapy area in 2023
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Novartis
Overview
6
- Premium Statistic Pharmaceutical market: worldwide revenue 2001-2023
- Premium Statistic Top 50 pharmaceutical companies - Rx sales and R&D spending 2022
- Premium Statistic Top 10 biotech and pharmaceutical companies based on market cap 2024
- Basic Statistic Gross margin ranking of top pharmaceutical companies 2022
- Premium Statistic Pharmaceutical companies - revenue from top 3 products 2022
- Premium Statistic Top therapy classes by spending global market 2027 forecast
Financials
5
Segments
4
Competitors
6
- Basic Statistic Projected top pharmaceutical companies based on sales 2023
- Premium Statistic Pfizer's total revenue 2006-2023
- Premium Statistic Merck & Co - total revenue 2006-2023
- Premium Statistic Johnson & Johnson's total sales 2005-2023
- Basic Statistic AbbVie's revenue 2010-2023
- Premium Statistic Roche Group's total sales 2006-2023
Research and development
4
- Premium Statistic Total global pharmaceutical R&D spending 2014-2028
- Premium Statistic Novartis' expenditure on research and development 2004-2023
- Premium Statistic Novartis' R&D expenditure as a percent of revenue 2004-2023
- Premium Statistic Top pharma companies worldwide 2024, by size of R&D pipeline
Outlook
4
- Premium Statistic Sales forecast of select blockbuster drugs by Novartis worldwide 2028
- Basic Statistic Sales forecast of select Novartis R&D projects worldwide 2028
- Premium Statistic Top pharma companies by cardio revenue worldwide 2023 and 2028
- Basic Statistic AI readiness of big pharma companies 2023
Further related statistics
14
- Spending growth of top pharmaceutical therapeutic classes by CAGR 2014-2018
- Novartis' spending on research and development by segment 2017-2023
- Dividends paid by Novartis AG 2009-2023
- Patients reached by Novartis AG's products 2009-2023
- Novartis' sales revenue in Spain 2012-2020
- Novartis' number of full-time employees 2009-2023
- Sanofi top pharmaceuticals revenue change 2023
- Members of EFPIA's pharmaceutical exports and imports 1990-2022
- Novartis' number of full-time employees by division 2013-2014
- U.S. human and veterinary pharmaceuticals - R&D spending 2017
- Pharmacy market sales' parallel import share - European countries 2021
- China's pharmaceutical market distribution 2011
- U.S. states with large employment in drugs and pharmaceuticals 2021
- Leading antiviral medicine brands in Russia Q1 2020, by sales share
Further Content: You might find this interesting as well
Statistics
- Spending growth of top pharmaceutical therapeutic classes by CAGR 2014-2018
- Novartis' spending on research and development by segment 2017-2023
- Dividends paid by Novartis AG 2009-2023
- Patients reached by Novartis AG's products 2009-2023
- Novartis' sales revenue in Spain 2012-2020
- Novartis' number of full-time employees 2009-2023
- Sanofi top pharmaceuticals revenue change 2023
- Members of EFPIA's pharmaceutical exports and imports 1990-2022
- Novartis' number of full-time employees by division 2013-2014
- U.S. human and veterinary pharmaceuticals - R&D spending 2017
- Pharmacy market sales' parallel import share - European countries 2021
- China's pharmaceutical market distribution 2011
- U.S. states with large employment in drugs and pharmaceuticals 2021
- Leading antiviral medicine brands in Russia Q1 2020, by sales share
Novartis. (January 31, 2024). Percentage of Novartis AG's pharmaceuticals revenue by therapy area in 2023 [Graph]. In Statista. Retrieved May 23, 2024, from https://www.statista.com/statistics/696248/novartis-pharmaceutical-revenue-share-by-therapy-area/
Novartis. "Percentage of Novartis AG's pharmaceuticals revenue by therapy area in 2023." Chart. January 31, 2024. Statista. Accessed May 23, 2024. https://www.statista.com/statistics/696248/novartis-pharmaceutical-revenue-share-by-therapy-area/
Novartis. (2024). Percentage of Novartis AG's pharmaceuticals revenue by therapy area in 2023. Statista. Statista Inc.. Accessed: May 23, 2024. https://www.statista.com/statistics/696248/novartis-pharmaceutical-revenue-share-by-therapy-area/
Novartis. "Percentage of Novartis Ag's Pharmaceuticals Revenue by Therapy Area in 2023." Statista, Statista Inc., 31 Jan 2024, https://www.statista.com/statistics/696248/novartis-pharmaceutical-revenue-share-by-therapy-area/
Novartis, Percentage of Novartis AG's pharmaceuticals revenue by therapy area in 2023 Statista, https://www.statista.com/statistics/696248/novartis-pharmaceutical-revenue-share-by-therapy-area/ (last visited May 23, 2024)
Percentage of Novartis AG's pharmaceuticals revenue by therapy area in 2023 [Graph], Novartis, January 31, 2024. [Online]. Available: https://www.statista.com/statistics/696248/novartis-pharmaceutical-revenue-share-by-therapy-area/